SUTRO BIOPHARMA, INC.
SEC Filing List
STRO CIK: 0001382101
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 05/15/2026 | ||||
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G/A | AKIN GUMP STRAUSS HAUER & FELD LLP LOS ANGELES OFFICE /FA/ | 05/14/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Sutro Biopharma, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/14/2026 | |
| 8-K | Current report filing | Sutro Biopharma, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/14/2026 | |
| SCHEDULE 13G | SEWARD & KISSEL LLP /fa | 05/01/2026 | |||
| DEFA14A | Definitive additional proxy soliciting m... | Sutro Biopharma, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/22/2026 | |
| ARS | Annual report to security holders | Sutro Biopharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/22/2026 | |
| DEF 14A | Definitive proxy statements | Sutro Biopharma, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/22/2026 | |
| SCHEDULE 13G/A | Toppan Merrill/FA | 04/21/2026 | |||
| No record found. | |||||
| Load More | |||||
